MIVI Neuroscience Overview
- Year Founded
-
2013

- Status
-
Private
- Employees
-
40

- Latest Deal Type
-
Mezzanine
- Latest Deal Amount
-
$510K
- Investors
-
6
MIVI Neuroscience General Information
Description
Operator of a clinical company intended to develop and commercialize clinical services for neuro-interventional procedures. The company's product portfolio provides physicians with unique devices to improve the safety and efficacy of interventional AIS therapy, enabling healthcare professionals to improve patient outcomes by reducing complications, shortening procedure times, and expanding treatment to more patients.
Contact Information
Website
www.mivineuro.comCorporate Office
- 6545 City West Parkway
- Eden Prairie, MN 55344
- United States
Corporate Office
- 6545 City West Parkway
- Eden Prairie, MN 55344
- United States
MIVI Neuroscience Timeline
MIVI Neuroscience Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
13. Mezzanine | 24-May-2024 | $510K | Completed | Generating Revenue | ||
12. Later Stage VC | 14-Jul-2023 | Completed | Generating Revenue | |||
11. Later Stage VC (Series B) | 29-Dec-2020 | Completed | Generating Revenue | |||
10. Debt - PPP | 01-May-2020 | Completed | Pre-Clinical Trials | |||
9. Later Stage VC | 14-May-2019 | Completed | Pre-Clinical Trials | |||
8. Later Stage VC (Series A) | 07-Feb-2019 | Completed | Pre-Clinical Trials | |||
7. Later Stage VC | 04-Dec-2018 | Completed | Startup | |||
6. Seed Round | 08-Aug-2018 | Completed | Startup | |||
5. Seed Round | 07-Sep-2017 | $1.64M | $10.2M | Completed | Startup | |
4. Seed Round | 18-Aug-2017 | $4.85M | $8.57M | Completed | Startup |
MIVI Neuroscience Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B-2 | ||||||||
Series B-1 | ||||||||
Series B | ||||||||
Series A | ||||||||
Seed-3 | ||||||||
Seed-2 | 725,020 | $0.000010 | $10.14 | $10.14 | 1x | $10.14 | 4.74% | |
Seed | 138,562 | $0.000010 | $8.58 | $8.58 | 1x | $8.58 | 0.91% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
MIVI Neuroscience Comparisons
Industry
Financing
Details
MIVI Neuroscience Competitors (25)
One of MIVI Neuroscience’s 25 competitors is Elixir Medical, a Venture Capital-Backed company based in Milpitas, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Elixir Medical | Venture Capital-Backed | Milpitas, CA | ||||
Medline Produtos Médicos e Hospitalares | Corporation | Sao Paulo, Brazil | ||||
Spartan Micro | Venture Capital-Backed | Costa Mesa, CA | ||||
Abiomed | Corporate Backed or Acquired | Danvers, MA | ||||
Globus Medical | Formerly VC-backed | Audubon, PA |
MIVI Neuroscience Patents
MIVI Neuroscience Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2024529438-A | A suction catheter system designed to improve suction and to evaluate suction status | Pending | 26-Jul-2021 | ||
CA-3227472-A1 | Suction catheter systems with designs allowing improved aspiration and evaluation of aspiration condition | Pending | 26-Jul-2021 | ||
EP-4376934-A1 | Suction catheter systems with designs allowing improved aspiration and evaluation of aspiration condition | Pending | 26-Jul-2021 | ||
EP-4376934-A4 | Suction catheter systems with designs allowing improved aspiration and evaluation of aspiration condition | Pending | 26-Jul-2021 | ||
JP-2023511958-A | Aspiration catheter system designed for rapid clot removal | Pending | 24-Jan-2020 | A61M25/09 |
MIVI Neuroscience Signals
MIVI Neuroscience Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Philips Ventures | Corporate Venture Capital | Minority | ||
Aphelion Capital | Venture Capital | Minority | ||
Perceptive Advisors | Venture Capital | Minority | ||
Concord Health Partners | Growth/Expansion | Minority | ||
Angel (individual) | Minority |
MIVI Neuroscience FAQs
-
When was MIVI Neuroscience founded?
MIVI Neuroscience was founded in 2013.
-
Where is MIVI Neuroscience headquartered?
MIVI Neuroscience is headquartered in Eden Prairie, MN.
-
What is the size of MIVI Neuroscience?
MIVI Neuroscience has 40 total employees.
-
What industry is MIVI Neuroscience in?
MIVI Neuroscience’s primary industry is Other Devices and Supplies.
-
Is MIVI Neuroscience a private or public company?
MIVI Neuroscience is a Private company.
-
What is MIVI Neuroscience’s current revenue?
The current revenue for MIVI Neuroscience is
. -
How much funding has MIVI Neuroscience raised over time?
MIVI Neuroscience has raised $79.7M.
-
Who are MIVI Neuroscience’s investors?
Philips Ventures, Aphelion Capital, Perceptive Advisors, Concord Health Partners, and are 5 of 6 investors who have invested in MIVI Neuroscience.
-
Who are MIVI Neuroscience’s competitors?
Elixir Medical, Medline Produtos Médicos e Hospitalares, Spartan Micro, Abiomed, and Globus Medical are some of the 25 competitors of MIVI Neuroscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »